Lundbeck

“Less than 3.5% of migraine patients who would benefit from monoclonal antibody treatment seek it.”

Fatima Del Reino Iniesta (Alicante)In Spain, less than 3.5% of candidate patients receive monoclonal antibody treatment for migraine, according to…

1 week ago

Brexpiprazole, a new oral antipsychotic that improves positive, negative, and affective symptoms of schizophrenia.

CompilationSchizophrenia does not affect everyone in the same way, so individual treatment important. In this sense, the emergence of a…

5 months ago